Klinikum Chemnitz

Inotuzumab Ozogamicin Induction Followed By Standard Chemotherapy Yields High Remission Rates and Promising Survival in Older (> 55 Years) Patients with De Novo B-Lymphoblastic Leukemia (GMALL-Initial1 Trial) (2022) Stelljes M, Alakel N, Waesch R, Scholl S, Nachtkamp K, Rank A, Haenel M, et al. Conference contribution Updated analysis of the phase II CheckRad-CD8 trial: First-line treatment of locally advanced head and neck squamous cell carcinoma with induction chemoimmunotherapy followed by radioimmunotherapy (2022) Hecht M, Eckstein M, Kallies A, von der Grün J, Illmer T, Klautke G, Laban S, et al. Conference contribution, Abstract of a poster Impact of IDH1 and IDH2 mutational subgroups in acute myeloid leukemia patients after allogeneic hematopoietic cell transplantation (2022) Kunadt D, Stasik S, Metzeler K, Roellig C, Kramer M, Greif P, Spiekermann K, et al. Conference contribution Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation (2022) Kunadt D, Stasik S, Metzeler KH, Roellig C, Schliemann C, Greif PA, Spiekermann K, et al. Journal article A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers (2022) Ademaj A, Veltsista PD, Marder D, Haelg RA, Puric E, Brunner TB, Crezee H, et al. Journal article Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations (2022) Eckardt JN, Stoelzel F, Kunadt D, Roellig C, Stasik S, Wagenfuehr L, Joehrens K, et al. Journal article F18-FDG PET/CT imaging early predicts pathologic complete response to induction chemoimmunotherapy of locally advanced head and neck cancer: preliminary single-center analysis of the checkrad-cd8 trial (2022) Beck M, Hartwich J, Eckstein M, Schmidt D, Gostian AO, Müller-Hübner S, Rutzner S, et al. Journal article An Analysis of the Use Pattern of Hyperthermia (HT) in Combination with Radio(chemo)therapy or Chemotherapy in European HT Centers (2022) Ademaj A, Veltsista DP, Marder D, Haelg RA, Puric E, Brunner TB, Crezee H, et al. Conference contribution Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD (2022) Stasik S, Kramer M, Zukunft S, Rollig C, Baldus CD, Platzbecker U, Serve H, et al. Journal article Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study (2022) Middeke JM, Metzeler KH, Rollig C, Kramer M, Eckardt JN, Stasik S, Greif PA, et al. Journal article